![LabX.com Logo](/labx_logo_small.png)
As advanced therapy techniques are evolving and gaining in popularity,
scientists are challenged to work faster and meet the growing patient demand.
To help labs keep pace, Thermo Scientific is offering a first-of-its-kind
shelving system to increase the capacity of incubators using the four
most-common cell culture production vessels. With the Thermo Scientific™
CultiMaxx™ shelving systems, the Thermo Scientific™ Heracell™ VIOS™ 250i and
Thermo Scientific™ Forma™ Steri-Cycle i250 CO2 incubators can
support up to a 150 percent increase of G-Rex bioreactors without compromising
performance. Advantages are found across a variety of incubator models and
vessel types, allowing scientists to scale-up their production of cell
therapies according to their preferred methods.
“Cell therapy is only at its beginning of transforming human health,” said Douglas Wernerspach, Sr. Business Director and General Manager—CO2 Incubators, Thermo Fisher Scientific. “Laboratories working in regenerative medicine will be challenged to keep pace with increased demand over the coming years. CultiMaxx Shelving Systems are an ideal offering for these scientists who want to scale up production of cultured cells quickly and efficiently, while retaining their current lab footprint.”
The CultiMaxx System is designed to fit more batches and improve vessel accessibility for the following large vessels when using select Thermo Scientific CO2 incubators:
Key applications
Cell therapy manufacturers, biotech companies and pharmaceutical companies who want to scale-up production of cultured cells, government/research/clinical institutions, and academic labs focusing on advanced therapies, regenerative therapies, stem cell therapies, cell culture research.
Features/Benefits: